BioForward Member News

12Sep 2017

Read the full article by Silke Schmidt at UW News here.  The National Science Foundation has awarded nearly $20 million to a consortium of universities, including the University of Wisconsin–Madison, to support a new engineering research center that will develop transformative tools and technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. Such […]

31Aug 2017

Read full article by DAVID WAHLBERG at the Wisconsin State Journal.  The UW School of Medicine and Public Health, Marshfield Clinic Research Institute and Medical College of Wisconsin have collectively been awarded $5.4 million from the National Institutes of Health to enroll patients in a nationwide precision medicine initiative. The institutions will partner with the Blood Center […]

24Aug 2017

Read the full article by Jeff Buchanan at Xconomy Wisconsin here.  The University of Wisconsin-Madison’s tech transfer office plans to invest $60 million in startups affiliated with the school over the next eight years and has launched a separate $50 million initiative aimed at commercializing UW-Madison research and discoveries in human therapeutics. Erik Iverson, managing […]

09Aug 2017

By Jeff Buchanan at Xconomy Wisconsin. Read the full article here.  Catch up on news from Wisconsin’s innovation community with these recent headlines: —The New York Times published a lengthy feature story about the efforts of Diane Hendricks, a billionaire corporate executive and philanthropist, to lead an economic revival in the city of Beloit. Hendricks is perhaps best […]

07Aug 2017

SHINE Breaks Ground on Building One August 4, 2017 Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a groundbreaking ceremony yesterday to celebrate the start of construction on Building One. The first building to be built for the […]

01Aug 2017

Source: Cellectar Biosciences, Inc. August 01, 2017 08:30 ET Cellectar Biosciences Signs Collaboration with Avicenna Oncology to Develop New PDCs for Solid Tumors MADISON, Aug. 01, 2017 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), today announces the initiation of a collaboration with Avicenna Oncology GmbH, a leading […]

01Aug 2017

Read the full article by Jeff Buchanan at Xconomy Wisconsin here.  Coverage and analysis of Taiwan-based Foxconn’s announcement that it will invest $10 billion to build an electronic display-making plant in Wisconsin has dominated business news around the state lately. However, there have also been numerous notable happenings apart from the Foxconn saga. Let’s catch […]